Warfarin sodium and Dermatomyositis - a phase IV clinical study of FDA data

Summary:

Dermatomyositis is reported as a side effect among people who take Warfarin sodium (warfarin sodium), especially for people who are female, 20-29 old, also take Cymbalta, and have Menstrual disorder.

The phase IV clinical study analyzes which people have Dermatomyositis when taking Warfarin sodium. It is created by eHealthMe based on reports of 67,331 people who have side effects when taking Warfarin sodium from the FDA, and is updated regularly.

What is Warfarin sodium?

Warfarin sodium has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 71,174 Warfarin sodium users. Check the latest studies of Warfarin sodium.

What is Dermatomyositis?

Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer) is found to be associated with 261 drugs and 416 conditions by eHealthMe. Check the latest studies of Dermatomyositis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

67,331 people reported to have side effects when taking Warfarin sodium.
Among them, 31 people (0.05%) have Dermatomyositis.

Could Warfarin sodium cause Dermatomyositis?

Among these 31 people:

What is the gender of people who have Dermatomyositis when taking Warfarin sodium? *

female: 88 %
male: 12 %

What is the age of people who have Dermatomyositis when taking Warfarin sodium? *

What are other drugs people take besides Warfarin sodium? *

Xarelto: 22 people, 70.97%
Cymbalta: 22 people, 70.97%
Rituxan: 12 people, 38.71%
Imuran: 9 people, 29.03%
Hydroxychloroquine Sulfate: 6 people, 19.35%
Prednisone: 6 people, 19.35%
Methotrexate: 5 people, 16.13%
Metformin Hydrochloride: 5 people, 16.13%
Sulfasalazine: 5 people, 16.13%
Azathioprine: 4 people, 12.90%

What are other side effects people have besides Dermatomyositis? *

Joint Range Of Motion Decreased (disease of joint movement): 23 people, 74.19%
Anovulatory Cycle (menstrual cycle during which the ovaries do not release an oocyte): 22 people, 70.97%
Nausea (feeling of having an urge to vomit): 22 people, 70.97%
Nasopharyngitis (inflammation of the nasopharynx): 22 people, 70.97%
Haemorrhage (bleeding): 22 people, 70.97%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 22 people, 70.97%
Hepatic Enzyme Increased: 22 people, 70.97%
Malaise (a feeling of general discomfort or uneasiness): 22 people, 70.97%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 22 people, 70.97%
Thrombosis (formation of a blood clot inside a blood vessel): 22 people, 70.97%

What are the existing conditions these people have? *

Weight Decreased: 22 people, 70.97%
Pain: 22 people, 70.97%
Menstrual Disorder (disease of menstrual cycle): 22 people, 70.97%
Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 9.68%
Depression: 2 people, 6.45%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 3.23%
Inflammation: 1 person, 3.23%
Ill-Defined Disorder: 1 person, 3.23%
High Blood Pressure: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Warfarin sodium and have Dermatomyositis?

- Check whether Dermatomyositis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Warfarin sodium:

Warfarin sodium (71,174 reports)

Dermatomyositis treatments and more:

Dermatomyositis (8,399 reports)

Browse all side effects of Warfarin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatomyositis:

Dermatomyositis (261 drugs)

Browse all the conditions that are associated with Dermatomyositis:

Dermatomyositis (416 conditions)

Related publications that referenced our studies

Kato, M., Oiso, N., Nozaki, Y., Inoue, A., Hosono, Y., Funauchi, M., ... & Kawada, A., "Antitumor necrosis factor alpha inhibitor‐induced dermatomyositis and interstitial lung disease with anti‐PL 12 autoantibody: Signs of antisynthetase syndrome", The Journal of dermatology, 2012 Jan .
Kato, M., Oiso, N., Nozaki, Y., Inoue, A., Hosono, Y., Funauchi, M., ... & Kawada, A., "Antitumor necrosis factor alpha inhibitor‐induced dermatomyositis and interstitial lung disease with anti‐PL 12 autoantibody: Signs of antisynthetase syndrome", The Journal of dermatology, 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on warfarin sodium (the active ingredients of Warfarin sodium) and Warfarin sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.